Trials / Conditions / Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

11 registered clinical trials studyying Mild to Moderate Atopic Dermatitis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult NCT07073677	HK inno.N Corporation	Phase 2
Unknown	Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatit NCT06052995	MEDA PHARMA SPA, a Viatris company	—
Completed	Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters NCT07166497	Pierre Fabre Dermo Cosmetique	—
Unknown	A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adu NCT05729074	HK inno.N Corporation	Phase 1
Completed	A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for NCT05057351	Greenpharma S.A.S.	N/A
Completed	Eucrisa for Atopic Dermatitis NCT03250663	Wake Forest University Health Sciences	Phase 1
Completed	Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 A NCT02079688	Sterna Biologicals GmbH & Co. KG	Phase 2
Completed	Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis NCT01568489	HanAll BioPharma Co., Ltd.	Phase 2
Completed	Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis NCT01079897	Bitop AG	N/A
Terminated	CT 327 in the Treatment of Atopic Dermatitis NCT00996008	Creabilis SA	Phase 2
Completed	A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis NCT00568412	Bayer	Phase 4